Em. Nakamura-palacios et al., Effects of the cannabinoid ligand SR 141716A alone or in combination with Delta(9)-tetrahydrocannabinol or scopolamine on learning in squirrel monkeys, BEHAV PHARM, 11(5), 2000, pp. 377-386
To investigate the effects of the cannabinoids on learning and on scopolami
ne-induced disruptions in learning, Delta(9)-tetrahydrocannabinol (Delta(9)
-THC), SR 141716A (an antagonist at CB1 receptors) and scopolamine were adm
inistered to squirrel monkeys responding in a repeated-acquisition task In
this task, monkeys acquired a different three-response sequence each sessio
n and responding was maintained by food presentation under a second-order f
ixed-ratio 5 schedule. When either Delta(9)-THC (0.1-0.56 mg/kg, i.m.) or S
R 141716A (1-10 mg/kg, i.m.) was administered alone, 60 and 75 min before t
he session, respectively, both cannabinoid ligands dose-dependently decreas
ed the overall rate of responding and increased the overall percentage of e
rrors. However, at a dose that had little or no effect alone (i.e. 1 mg/kg)
, SR 141716A antagonized the disruptive effects of Delta(9)-THC (0.18-1.8 m
g/kg) on acquisition, shifting the dose-effect curves for rate of respondin
g and percentage of errors at least 1/2 log unit to the right. Finally, whe
n either Delta(9)-THC (0.001-1 mg/kg) or SR 141716A (0.32-10 mg/kg) was adm
inistered with scopolamine (0.01 or 0.032 mg/kg, 15 min before the session)
, greater rate-decreasing and error-increasing effects were obtained than w
ith scopolamine alone. These results suggest that while low doses of SR 141
716A can antagonize the effects of Delta(9)-THC in squirrel monkeys, high d
oses can also disrupt acquisition when administered alone and potentiate th
e disruptive effects of scopolamine on acquisition. (C) 2000 Lippincott Wil
liams & Wilkins.